AnalystsJamie ClarkJamie Clark's Stock Forecasts
AnalystsJamie Clark
Sectors:
Analyst Ranking
Bottom 34%
#3443 out of 5192 analysts
Average Return
-0.18%
Win Rate
57%4 out of 7
Risk vs Reward
Poor
Good
Jamie Clark's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Quest Diagnostics IncDGX | +23.16% | $167.96 | $206.86 | 2025-04-02 - 2026-02-12 | Strong Buy |
Labcorp Holdings IncLH | +17.66% | $236.37 | $278.11 | 2025-04-02 - 2026-02-12 | Strong Buy |
Charles River Laboratories International IncCRL | +16.10% | $136.73 | $158.74 | 2025-05-23 - 2026-02-12 | Strong Buy |
Charles River Laboratories International IncCRL | +15.35% | $193.14 | $163.50 | 2024-10-14 - 2025-03-03 | Strong Sell |
Jamie Clark Analyst Color
Get additional color on Jamie Clark's coverage of popular stocks
Jamie Clark's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
West Pharmaceutical Services IncWST | 1 | Strong Buy | $311.00 | +27.66% | Initiates Coverage On | 5 months ago |
Medpace Holdings IncMEDP | 1 | Hold | $474.00 | +13.93% | Downgrades | 5 months ago |
Icon PLCICLR | 1 | Strong Buy | $236.00 | +194.71% | Upgrades | 5 months ago |
Charles River Laboratories International IncCRL | 3 | Strong Buy | $182.00 | +14.65% | Upgrades | 9 months ago |
Labcorp Holdings IncLH | 1 | Strong Buy | $276.00 | -0.76% | Initiates Coverage On | 10 months ago |
Quest Diagnostics IncDGX | 1 | Strong Buy | $195.00 | -5.73% | Initiates Coverage On | 10 months ago |
Iqvia Holdings IncIQV | 1 | Strong Buy | $276.00 | N/A | Initiates Coverage On | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.